Evaluation of Humoral Response to SARS-CoV-2 after Two-Doses of the ChAdOx1 nCoV-19 Vaccine (Astrazeneca) in a Cohort from Rio de Janeiro, Brazil
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.